Magnetar Financial’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-40,075
| Closed | -$801K | – | 593 |
|
|
2024
Q3 | $801K | Sell |
40,075
-3,672,183
| -99% | -$73.4M | 0.02% | 294 |
|
|
2024
Q2 | $41.5M | Sell |
3,712,258
-947,120
| -20% | -$10.6M | 0.87% | 41 |
|
|
2024
Q1 | $30.8M | Sell |
4,659,378
-1,623,178
| -26% | -$10.7M | 0.69% | 53 |
|
|
2023
Q4 | $28.4M | Buy |
6,282,556
+408,378
| +7% | +$1.85M | 0.72% | 44 |
|
|
2023
Q3 | $21M | Sell |
5,874,178
-161,360
| -3% | -$578K | 0.54% | 60 |
|
|
2023
Q2 | $22.3M | Sell |
6,035,538
-1,039,184
| -15% | -$3.83M | 0.49% | 66 |
|
|
2023
Q1 | $23.4M | Buy |
7,074,722
+887,406
| +14% | +$2.94M | 0.46% | 60 |
|
|
2022
Q4 | $24M | Buy |
6,187,316
+1,815,908
| +42% | +$7.05M | 0.41% | 59 |
|
|
2022
Q3 | $10.6M | Sell |
4,371,408
-2,489,464
| -36% | -$6.05M | 0.15% | 172 |
|
|
2022
Q2 | $13.6K | Buy |
6,860,872
+351,955
| +5% | +$697 | 0.14% | 141 |
|
|
2022
Q1 | $11.9M | Sell |
6,508,917
-626,031
| -9% | -$1.15M | 0.13% | 163 |
|
|
2021
Q4 | $10.1M | Buy |
7,134,948
+6,323,986
| +780% | +$8.92M | 0.1% | 204 |
|
|
2021
Q3 | $916K | Buy |
810,962
+204,831
| +34% | +$231K | 0.01% | 743 |
|
|
2021
Q2 | $970 | Sell |
606,131
-11,791
| -2% | -$19 | 0.01% | 736 |
|
|
2021
Q1 | $1.09M | Buy |
617,922
+58,410
| +10% | +$103K | 0.01% | 682 |
|
|
2020
Q4 | $1.09M | Buy |
559,512
+199,531
| +55% | +$389K | 0.02% | 449 |
|
|
2020
Q3 | $860K | Buy |
359,981
+218,458
| +154% | +$522K | 0.02% | 364 |
|
|
2020
Q2 | $415K | Sell |
141,523
-250,700
| -64% | -$735K | 0.01% | 293 |
|
|
2020
Q1 | $1.13M | Buy |
392,223
+320,000
| +443% | +$922K | 0.03% | 151 |
|
|
2019
Q4 | $289K | Buy |
72,223
+22,223
| +44% | +$88.9K | 0.01% | 450 |
|
|
2019
Q3 | $223K | Buy |
+50,000
| New | +$223K | 0.01% | 430 |
|